Stochastic modulation evidences a transitory EGF-Ras-ERK MAPK activity induced by PRMT5

Area of Science:

• Cellular signaling and molecular biology.
• Computational modeling of biological pathways.

Background:

• The extracellular signal-regulated kinase (ERK) mitogen-activated protein kinase (MAPK) pathway is crucial for cell growth, development, and apoptosis.
• Aberrant MAPK pathway activity is linked to cell proliferation diseases and tumor formation.

Purpose of the Study:

• To investigate the role of protein arginine methyltransferase 5 (PRMT5) in modulating the ERK-MAPK pathway.
• To develop computational models simulating PRMT5's influence on the epidermal growth factor (EGF)-Ras-ERK pathway.

Main Methods:

• Utilized simulation modeling to create two computational models of the EGF-Ras-ERK MAPK pathway.
• Investigated PRMT5's impact on Raf kinase activity and subsequent ERK activation under different activation scenarios.

Main Results:

• PRMT5 methylation of Raf kinase reduces its catalytic activity, dampening ERK activation in both time and amplitude.
• PRMT5 limits the range of EGF concentrations that trigger ERK activation in one model.
• PRMT5 consistently reduces ERK activation duration and expression levels.

Conclusions:

• PRMT5 acts as a negative regulator of the ERK-MAPK pathway.
• PRMT5's regulatory function suggests its potential as a therapeutic target for diseases driven by excessive MAPK activity, including cancer.